Hyperthyroidism happens when the thyroid gland produces more hormone than the body needs, speeding up metabolism and affecting nearly every organ system. The most common cause by far is Graves’ disease, an autoimmune condition responsible for 60% to 80% of all cases. The remaining cases stem from overactive thyroid nodules, inflammation that causes stored hormone to leak into the bloodstream, excess iodine intake, certain medications, and rarely, a pituitary tumor.
Graves’ Disease
In Graves’ disease, the immune system produces antibodies that mimic the signal your brain normally sends to the thyroid. These antibodies latch onto receptors on thyroid cells and tell them to keep producing hormone, even when the body already has more than enough. Because the antibodies also stimulate gland growth, people with Graves’ disease often develop a visibly enlarged thyroid, sometimes called a goiter.
Graves’ disease is far more common in women than men. Data from the UK puts the prevalence of hyperthyroidism at about 1.3% in adult women and 0.25% in men, with most of those cases driven by Graves’ disease. Genetics play a meaningful role: certain immune-system genes roughly double a person’s risk. The strongest genetic link in people of European descent involves a specific set of immune markers found in about half of all Graves’ patients but only 25% to 30% of the general population. Other genes involved in regulating T cells and thyroid function each add smaller increments of risk, with individual odds increases ranging from about 10% to 100% depending on the gene.
Toxic Nodules and Multinodular Goiter
Sometimes one or more lumps (nodules) in the thyroid start producing hormone on their own, ignoring the body’s normal feedback signals. When a single nodule does this, it’s called a toxic adenoma. When several nodules overproduce at once, the condition is toxic multinodular goiter. Despite appearing different clinically, both share the same underlying problem in most cases: a mutation in the gene for the thyroid’s main receptor. Research has found these mutations in roughly 72% of toxic adenomas and 83% of overactive nodules within multinodular goiters.
Toxic multinodular goiter tends to develop gradually, often in older adults who have had a slowly growing goiter for years. A single toxic adenoma can appear at any age but is more common in younger patients. Both conditions produce a milder, more slowly progressive form of hyperthyroidism compared to Graves’ disease. Blood tests typically show low levels of the pituitary hormone that controls the thyroid (TSH), sometimes with only modestly elevated thyroid hormone levels, a pattern called subclinical hyperthyroidism.
Thyroiditis: Inflammation That Releases Stored Hormone
The thyroid stores a significant reserve of pre-made hormone. When the gland becomes inflamed, that stored hormone can leak into the bloodstream all at once, producing a temporary spike. This is fundamentally different from Graves’ disease or toxic nodules, where the gland is actively overproducing. With thyroiditis, the gland is being damaged, and the hyperthyroidism only lasts until the stored supply runs out, typically a few weeks to a few months.
Several types of thyroiditis can trigger this pattern:
- Postpartum thyroiditis affects roughly 5% to 10% of women in the year after delivery. It involves immune cells infiltrating the thyroid, and the hyperthyroid phase typically hits between 1 and 4 months postpartum. About 30% of affected women experience only the hyperthyroid phase, 43% skip straight to a hypothyroid (underactive) phase, and 25% go through the classic pattern of hyperthyroidism followed by hypothyroidism before the gland recovers.
- Subacute thyroiditis often follows a viral illness and causes neck pain along with thyroid tenderness. The hyperthyroid phase resolves on its own as the inflammation settles.
- Silent thyroiditis resembles postpartum thyroiditis but occurs outside of pregnancy, with painless inflammation and a similar temporary hormone release.
A thyroid uptake scan can distinguish between these causes. In thyroiditis, the gland’s ability to absorb iodine is low because it’s not actively making new hormone. In Graves’ disease, uptake is high because the gland is in overdrive.
Excess Iodine Intake
The thyroid needs iodine to manufacture its hormones, and normally the gland self-regulates. When you take in a large dose of iodine, production temporarily slows down as a protective measure. In some people, though, the gland escapes this safety brake and instead ramps up hormone production. This is known as iodine-induced hyperthyroidism, and it’s most likely to occur in people who already have underlying thyroid abnormalities like nodules or early Graves’ disease.
Common sources of high iodine loads include contrast dyes used in CT scans and certain imaging procedures, iodine-based antiseptic solutions, and dietary supplements. The growing popularity of iodine-containing supplements and seaweed products means this trigger is becoming more relevant. If you have a known thyroid condition, it’s worth checking supplement labels and mentioning your thyroid history before any imaging procedure that uses contrast dye.
Medication-Induced Hyperthyroidism
The heart medication amiodarone is the most well-known drug trigger for hyperthyroidism, partly because it contains 37% iodine by weight. It causes thyroid overactivity through two distinct pathways. In patients who already have a thyroid abnormality like a goiter or latent Graves’ disease, the iodine load can push the gland into overproduction. This tends to happen relatively quickly, with a median onset of about 3 months after starting the medication.
The second pathway is a direct toxic effect on thyroid tissue, which damages cells and causes them to release their stored hormone. This form typically takes longer to develop, with a median onset around 30 months, and generally resolves within one to three months once the stored hormone is depleted. Some patients who go through this destructive process eventually become hypothyroid because the gland itself has been damaged. Distinguishing between these two forms matters because they require different treatments, but the distinction is often difficult to make even for specialists.
Pituitary Tumors
In rare cases, hyperthyroidism originates not in the thyroid but in the pituitary gland at the base of the brain. The pituitary normally controls the thyroid by releasing TSH, the hormone that tells the thyroid how much to produce. A TSH-secreting pituitary tumor continuously pumps out TSH regardless of how much thyroid hormone is already circulating, driving the thyroid to overproduce. These tumors account for only about 1% of all pituitary adenomas, making them an uncommon cause.
The hallmark on blood tests is unusual: thyroid hormone levels are high, but TSH is normal or elevated rather than suppressed. In every other form of hyperthyroidism, TSH drops to nearly undetectable levels because the pituitary is trying to tell the thyroid to slow down. When TSH stays inappropriately normal or high despite elevated thyroid hormones, it points to either a pituitary tumor or a rare genetic condition called resistance to thyroid hormone. Headaches, visual changes, or signs of other hormonal imbalances (such as unexpected breast milk production or changes in growth hormone) can further suggest a pituitary origin, and MRI of the brain is used to confirm it.
Who Is Most at Risk
Women are significantly more likely to develop hyperthyroidism than men. Autoimmune thyroid disease is roughly twice as common in women, with estimates of 7.7% of adult women affected compared to 2.7% of men. Family history matters: having a close relative with any autoimmune thyroid condition, whether Graves’ disease or its counterpart Hashimoto’s thyroiditis, increases your risk. Smoking is an established environmental risk factor, particularly for Graves’ disease and the eye complications that sometimes accompany it.
Age and geography also play roles. Toxic multinodular goiter is more common in older adults and in regions where dietary iodine has historically been low. Graves’ disease peaks in middle age but can appear at any point in life, including childhood. People with other autoimmune conditions like type 1 diabetes, rheumatoid arthritis, or celiac disease face a higher likelihood of developing autoimmune thyroid disease as well.